Literature DB >> 21211107

Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.

Matthias Klugmann1, Viktoria Klippenstein, F Markus Leweke, Rainer Spanagel, Miriam Schneider.   

Abstract

Recent evidence suggests an involvement of the endocannabinoid system in the regulation of emotional behaviour and ethanol intake. Here we investigated age-specific acute behavioural effects of the cannabinoid receptor agonist WIN 55,212-2 (WIN) on anxiety-related behaviour and voluntary ethanol consumption in rats. Animals were treated with WIN (1.2 mg/kg)/vehicle at puberty onset on postnatal day (PD) 40, or at adulthood (PD 100). Animals were tested in the elevated plus-maze (EPM) and the light/dark emergence test (EMT) and for the initial response to alcohol in a free-choice ethanol consumption paradigm. Acute WIN treatment increased anxiety-related behaviours, and this effect was found to be partially more pronounced in pubertal than adult rats. Additionally, increased intake of higher ethanol solutions after cannabinoid treatment was only observed in pubertal rats. These drug-induced behavioural changes during puberty are paralleled by induction of the NR1 subunit of the NMDA receptor in the medial prefrontal cortex and the striatum. Moreover, pubertal but not adult WIN administration increased the levels of the scaffold protein Homer in these brain regions. Enhanced CB₁ receptor levels in the reinforcement system were also observed in pubertal compared to adult rats. These data support the notion that puberty is a highly vulnerable period for the aversive effects of cannabinoid exposure. In particular, augmented ethanol intake in pubertal cannabinoid-exposed animals might be related to some extent to increased emotional behaviour and in particular to enhanced NMDA and CB₁ receptor signalling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211107     DOI: 10.1017/S1461145710001562

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  15 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

Review 2.  Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors:  Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal:  Psychoneuroendocrinology       Date:  2014-10-22       Impact factor: 4.905

Review 3.  Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-26       Impact factor: 4.328

Review 4.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

Review 5.  Reward-centricity and attenuated aversions: An adolescent phenotype emerging from studies in laboratory animals.

Authors:  Tamara L Doremus-Fitzwater; Linda P Spear
Journal:  Neurosci Biobehav Rev       Date:  2016-08-11       Impact factor: 8.989

6.  Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring.

Authors:  John J Byrnes; Nicole L Johnson; Marian E Schenk; Elizabeth M Byrnes
Journal:  J Psychopharmacol       Date:  2012-04-19       Impact factor: 4.153

7.  Altered patterns of filopodia production in CHO cells heterologously expressing zebra finch CB(1) cannabinoid receptors.

Authors:  Ken Soderstrom; Yuguo Zhang; Ashley R Wilson
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

Review 8.  Medical Use of Cannabinoids.

Authors:  Ana Isabel Fraguas-Sánchez; Ana Isabel Torres-Suárez
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

9.  Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.

Authors:  Miriam Schneider; Fernando Kasanetz; Diane L Lynch; Chris M Friemel; Olivier Lassalle; Dow P Hurst; Frauke Steindel; Krisztina Monory; Carola Schäfer; Isabelle Miederer; F Markus Leweke; Mathias Schreckenberger; Beat Lutz; Patricia H Reggio; Olivier J Manzoni; Rainer Spanagel
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

10.  Differential phosphorylation of GluN1-MAPKs in rat brain reward circuits following long-term alcohol exposure.

Authors:  Yongsheng Zhu; Yunpeng Wang; Bin Zhao; Shuguang Wei; Ming Xu; Enqi Liu; Jianghua Lai
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.